A new DRUG TRIAL SNAPSHOT FOR ALECENSA is now available. ALECENSA is a drug used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that is advanced (metastatic). It is to be used in patients who have a specific gene rearrangement in what is called the anaplastic lymphoma kinase (ALK) gene. It should be used only in patients whose cancer has worsened after, or who could not tolerate treatment with another drug called Xalkori (crizotinib).
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov
.png)
No hay comentarios:
Publicar un comentario